Vaccine/Variant Whack-a-Mole: Concerns raised that slow vaccine rollout, combined with incomplete strategies to prevent infection and spread can lead to a greater risk of further coronavirus mutations and reduced vaccine efficacy.

Dr. Barry Dworkin

Medical Mythbusting Commentary for February 1, 2021

[display_podcast]

Source:
New clinical trials raise fears the coronavirus is learning how to resist vaccines

Related posts:

  1. Pfizer COVID-19 vaccine news is a press release not a study. No raw data to review, limited transparency, basic questions unanswered, 94 cases, and an overreaction focusing on the claim of 90% efficacy. Validated evidence required to justify the hype.
  2. Second dose of Pfizer and AstraZeneca vaccine needed to reach maximum efficacy against variant from India.
  3. Nasal flu vaccine still recommended for children in Canada. Data from US differs in part because of better study design
  4. Calgary obstetric clinic posts notice not to bring unvaccinated children to their office to reduce the risk of harm to pregnant women and their newborn children. To those complaining, what are your health policy reasons for rejecting this proposal?